Page 10 - ஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் மாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merus N V : Merus to Participate in a Fireside Chat at the Jefferies Virtual Healthcare Conference

Merus N.V.: Merus to Participate in a Fireside Chat at the Jefferies Virtual Healthcare Conference and Triclonics ), today announced that Bill Lundberg, M.D., Chief Executive Officer of Merus, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2 at 9:00 a.m. ET. The live webcast of the presentation will be available on the Investors page of the Company s website. An archived presentation will be available on the Merus website for a limited time. About Merus Merusis a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics

United kingdomKathleen farrenCommunications specialistBill lundbergChief executive officerJefferies virtual healthcare conferenceMedia inquiriesஒன்றுபட்டது கிஂக்டம்க்யாத்லீந் ஃப்யாரந்தகவல்தொடர்புகள் நிபுணர்ர சி து லண்ட்பெர்க்தலைமை நிர்வாகி அதிகாரிஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் மாநாடுமீடியா விசாரணைகள்

NANOBIOTIX to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

Regulatory News: NANOBIOTIX (Euronext: NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for

United kingdomFrance generalUnited statesBrandon owensKate mcneilPorter novelliPierre louis germainCommunications departmentInvestor relations departmentRegulatory newsLaurent levyJefferies virtual healthcare conferenceEuropean timeNasdaq global select marketNew york cityInvestor relations

Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesDavid pittsJoseph olivetoMilestone pharmaceuticals incCompany on twitter at milestonepharmaMilestone pharmaceuticalsChief executive officerJefferies virtual healthcare conferenceஒன்றுபட்டது மாநிலங்களில்டேவிட் குழிகள்ஜோசப் ஆலிவேடோமைல்கல் மருந்துகள் இன்க்மைல்கல் மருந்துகள்தலைமை நிர்வாகி அதிகாரிஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் மாநாடு

Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference on June 2, 2021

Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference on June 2, 2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jacqueline kirbyAndrean flynnCorporate affairs government relationsPrnewswire jazz pharmaceuticalsJazz pharmaceuticalsJefferies virtual healthcare conferenceCorporate affairsஜாக்குலின் கர்பீஆண்ட்ரியன் ஃப்லிந்பெருநிறுவன வாழ்க்கைத்தொழில்கள் அரசு உறவுகள்ஜாஸ் மருந்துகள்ஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் மாநாடுபெருநிறுவன வாழ்க்கைத்தொழில்கள்

Investegate |NuCana plc Announcements | NuCana plc: NuCana to Present at the Jefferies Virtual Healthcare Conference

NuCana to Present at the Jefferies Virtual Healthcare Conference EDINBURGH, United Kingdom, May 25, 2021 (GLOBE NEWSWIRE) NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Jefferies Virtual Healthcare Conference being held from June 1 to June 4, 2021. Event: Jefferies Virtual Healthcare Conference Date: Tuesday, June 1, 2021 Time: 9:30 AM ET The presentation will be webcast live and available for replay under “Events & Presentations” in the Investors section of the Company s website at www.nucana.com. About NuCana NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. While these conventional agents remain p

United kingdomCity ofDon munozHughs griffithHugh griffithMarion janicChris brinzeyExchange commissionCompany annual report on formJefferies virtual healthcareChief executive officerChief financial officerJefferies virtual healthcare conferencePrivate securities litigation reform actAnnual reportInvestegate announcements